Morning Forecast: Monday, 6 April
The Chart Training Course Is Live
This content is for informational and educational purposes only and does not constitute financial advice. Always do your own research. Not financial advice (NFA).
Chart Training Course + Private Indicators Are Now Live
11 modules. 3 private indicators. Peer-reviewed research behind every claim.
Why 95% Lose — And How to Be in the 5%
A complete chart analysis framework covering trends, moving averages, momentum, divergence, patterns, position sizing, risk management, and the Sensei Trade Checklist.
Built for crypto, equities, and indices. The same framework I use every day.
This is not theory. This is not hype. Every claim is backed by academic research. Every module is designed to give you a repeatable system you can apply from tomorrow.
🎥 Watch the course + PDFs, indicators & TradingView setup:
Why 95% Lose And How to Be in the 5%
The full premium chart analysis training course. 11 modules covering trends, moving averages, support and resistance, momentum, divergence, chart patterns, the Sensei Trade Checklist, position sizing, risk management, and how to stay in the 5%.
Go watch it. Apply it. Prove the 95% wrong.
👀 Today’s Stories at a Glance
🕊️ Pakistan Brokers Peace Plan: Islamabad proposes a two-phase ceasefire to reopen the Strait of Hormuz before Trump’s Tuesday deadline.
📊 Wall Street Fears Inflation: Investors await the March CPI report as war-driven oil prices threaten to spark historic stagflation.
💊 Trump Signs Drug Tariffs: New executive orders impose 100% duties on imported medicines unless companies manufacture within the U.S.
🛢️ OPEC+ Boosts Production Quotas: A symbolic output hike offers little relief while the Strait remains blocked by Iranian naval forces.
🇨🇳 Chinese Bond Yields Rise: External energy shocks are ending years of deflation, pushing government bond yields toward a 2% inflection.
🧠 One Big Thing
The Fed Independence Standoff
A federal judge recently blocked Justice Department subpoenas targeting Federal Reserve Chair Jerome Powell, citing a lack of criminal evidence and potential political motives to force interest rate cuts. This legal battle has evolved into a broader defense of central bank autonomy, supported by a bipartisan coalition of former economic officials and banking leaders. The conflict now centers on the April 16 confirmation hearing for Powell’s proposed successor, Kevin Warsh. Senator Thom Tillis intends to block this nomination while the government appeals the subpoena ruling. For investors, this creates a period of high uncertainty regarding the leadership transition and future monetary policy. A delayed confirmation reinforces Fed independence but risks increased Treasury volatility as Powell’s term expiration nears on May 15.
⚖️ Fear & Greed
📉 The Number That Matters
$400 TRILLION
The total value of global financial assets currently dwarfing the tokenized market. The IMF warns that migrating this massive capital to automated platforms removes the “time buffers” of traditional settlement, potentially triggering “flash crashes” faster than human regulators can intervene.
⚔️ Winners vs Losers
Winners
SLNO 0.00%↑: Soleno Therapeutics surged after Neurocrine Biosciences announced a definitive agreement to acquire the company for $53.00 per share in cash, valuing it at approximately $2.9 billion, a 34% premium to its last close.
DEFT 0.00%↑: DeFi Technologies continued to rally after reporting record annual revenue of $99.1 million for fiscal 2025, a 215% year-over-year increase, alongside record net income of $62.7 million.
APPF 0.00%↑: AppFolio, Inc. jumped ahead of its upcoming Q1 earnings report on April 23, with analysts expecting year-over-year growth in both earnings and revenue. No specific catalyst identified for today’s move.
PRAX 0.00%↑: Praxis Precision Medicines rallied as investors continued to price in momentum from the FDA’s acceptance and priority review of its NDA for relutrigine, with a PDUFA target date of September 27, 2026, which would be the first approved therapy for SCN2A/SCN8A developmental epileptic encephalopathies.
SPCE 0.00%↑: Virgin Galactic Holdings rallied following its recent business update, which included the start of ground testing for its first new SpaceShip in April and the launch of ticket sales for Spaceflight Expeditions priced at $750,000.
LWLG 0.00%↑: Lightwave Logic continued its momentum after integrating its electro-optic polymer high-speed modulator platform into the GDSFactory design kit supporting GlobalFoundries’ silicon photonics, and signing a new development agreement with Tower Semiconductor targeting AI data center applications.
AAOI 0.00%↑: Applied Optoelectronics continued climbing after announcing a new $71 million order for 800G single-mode data center transceivers from a major hyperscale customer, bringing total orders from that customer to $124 million since mid-March.
SNDK 0.00%↑: Sandisk Corporation edged higher as part of its broader 2026 rally, with shares up roughly 1,350% since spinning off from Western Digital in early 2025, driven by surging AI-related NAND flash demand across hyperscale data centers.
Losers
AESI 0.00%↑: Atlas Energy Solutions fell after cutting Q1 2026 adjusted EBITDA guidance to $26-$30 million, citing severe winter weather and unplanned maintenance at its Kermit facility, compounded by broader energy sector weakness from falling oil prices.
📊 Market Snapshot
Cryptocurrencies:
Bitcoin (BTC): $69348 (▲ 0.48%)
Ethereum (ETH): $2146 (▲ 1.75%)
XRP: $1.34 (▲ 1.27%)
Equity Indices (Futures):
S&P 500: $6591 (▲ 0.42%)
NASDAQ 100: $24317 (▲ 0.77%)
FTSE 100: £10452 (▲ 0.31%)
Commodities & Bonds:
10-Year US Treasury Yield: 4.33% (▲ 0.56%)
Oil (WTI): $110 (▼ -1.53%)
Gold: $4677 (▲ 0.00%)
Silver: $73.15 (▲ 0.19%)
Data as of: UK (GMT) 13:54 / US (EST): 08:54 / Asia (Tokyo): 22:54
✅ 5 Things to Know Today
🕊️ Pakistan Brokers Last-Ditch Peace Plan as Trump’s Tuesday Deadline Looms
A Pakistani-brokered ceasefire framework landed on both Washington’s and Tehran’s desks overnight, offering the first structured pathway to ending the five-week-old conflict. Pakistan’s army chief, Field Marshal Asim Munir, was in contact “all night long” with Vice President JD Vance, special envoy Steve Witkoff, and Iranian Foreign Minister Abbas Araghchi, according to a source familiar with the proposals. The plan follows a two-phase structure: an immediate ceasefire and partial reopening of the Strait of Hormuz, followed by 15 to 20 days of negotiations toward a comprehensive settlement. Separately, Axios reported that mediators are discussing a potential 45-day ceasefire as the first phase. The framework has been tentatively dubbed the “Islamabad Accord,” with final terms to be signed electronically through Pakistan as the sole communication channel (CNBC).
Iran’s response has been measured but resistant. A senior Iranian official told Reuters today that Tehran will not reopen the Strait of Hormuz as part of a temporary ceasefire, adding that Iran “won’t accept deadlines” as it reviews the proposal. The official also said Washington lacks the readiness for a permanent ceasefire. The Strait, which normally carries roughly 20% of the world’s oil and natural gas supply, has been effectively closed since early March, and Iran views control over it as its primary bargaining chip. Mediators are working on confidence-building measures that would see Iran take partial steps on both the Strait and its highly enriched uranium stockpile during a first phase, without fully surrendering either card for just 45 days of ceasefire (Al Jazeera).
Meanwhile, President Trump extended his infrastructure strike deadline to Tuesday at 8:00 PM Eastern Time, after initially setting it for today. Yesterday, he posted an expletive-laden message on Truth Social threatening to turn Iran’s power plants and bridges into rubble if the Strait stays shut. “Tuesday will be Power Plant Day, and Bridge Day, all wrapped up in one, in Iran,” he wrote. This is the third time Trump has set and then shifted a deadline for Iran, having previously postponed on March 23 and March 26, each time citing progress in talks. Markets have learned to partially discount these ultimatums, but the escalation cycle is accelerating: strikes on civilian infrastructure by both sides intensified over the weekend, with Iran hitting petrochemical facilities in Kuwait, Bahrain, and the United Arab Emirates. Over 100 legal scholars have warned that targeting civilian power infrastructure could constitute war crimes under the Geneva Conventions. The Tuesday deadline now functions as a binary event for markets: another extension and relief rally, or follow-through and a sharp repricing of risk across every asset class.
Sensei’s Insight: Three deadlines, three extensions. Markets have started treating Trump’s ultimatums like a boy crying wolf, and the paper price of oil has stayed well below the physical delivery price partly because traders keep betting on de-escalation. That gap between paper and physical Brent, which hit $30 a barrel on April 2, is the clearest measure of how much complacency is priced in. If Tuesday’s deadline actually triggers action, that gap closes violently.
📊 Wall Street Braces for Inflation’s First War Snapshot
Three inflation reports land this week, and the one that matters most arrives on April 10. The March Consumer Price Index (CPI), due at 8:30 AM Eastern, will be the first major inflation reading to fully capture the impact of the Iran war and the oil price surge that followed it. Economists surveyed by Bloomberg are forecasting a 0.9% to 1.0% monthly increase in headline CPI, which would be the sharpest one-month advance since 2022. The Cleveland Federal Reserve’s Inflation Nowcasting tool estimates March CPI at approximately 3.16% year-over-year, a jump of 76 basis points from February’s 2.4% reading. The driver is straightforward: national average gasoline prices climbed from roughly $2.92 per gallon before the war to $4.09 today, an increase of about $1.17 in a single month. Diesel has broken above $5.50 per gallon, and jet fuel prices are up 104% according to the International Air Transport Association (Bloomberg).
Before the CPI, the February Personal Consumption Expenditures (PCE) Price Index, the Federal Reserve’s preferred inflation measure, drops later this week. That report covers a period largely before the war began, but it will still show core PCE rising 0.4% monthly for the third consecutive month, confirming inflation was already sticky before oil added fuel to the fire. The broader picture is one of stagflation risk building fast. The March jobs report, released on April 3, showed the economy added 178,000 positions, nearly triple the 59,000 consensus, but Goldman Sachs estimated that weather effects, strike resolutions at Kaiser Permanente, and seasonal adjustments accounted for roughly 122,000 of those gains. More telling was wage growth, which slowed to 3.4% annually, the weakest since 2021. With the Organisation for Economic Co-operation and Development (OECD) now forecasting United States headline inflation at 4.2% for 2026, real wages are turning negative for the first time in years. Wells Fargo economists described the combination of weakening wage growth and rising prices as “the FOMC’s worst nightmare” (CNBC).
Sensei’s Insight: The March CPI number is already priced in. What matters more is April, because oil was still climbing after the March survey window closed. If the print comes in above 1%, the market conversation shifts from “will the Fed hold?” to “could the Fed hike?” and that repricing has barely started in rate-sensitive sectors like homebuilders and small caps.
💊 Trump Slaps 100% Tariffs on Patented Drugs
President Trump signed an executive order on April 2 imposing 100% tariffs on imported patented pharmaceutical products and their active ingredients under Section 232 of the Trade Expansion Act of 1962, the same national security authority previously used for steel and aluminium. The policy creates a tiered system: companies that sign a “Most Favoured Nation” (MFN) pricing deal with the Department of Health and Human Services (HHS) and commit to building manufacturing in the United States pay nothing. Those building domestically without a pricing deal face 20%, rising to 100% over four years. Companies that do neither face the full 100% rate once the phase-in period ends: July 31 for large firms, late September for smaller ones. More than 13 companies, including Eli Lilly, Pfizer, Johnson & Johnson, and Novo Nordisk, have already signed MFN agreements. Generic drugs, biosimilars, and orphan drugs are exempt (CNBC).
The order landed differently depending on company size. Major pharmaceutical firms with the capital to build new plants and the leverage to negotiate pricing deals have a clear pathway to exemption. For mid-sized biotech companies with one or two patented products and no domestic manufacturing footprint, the calculus is far more difficult. The Mid-sized Biotech Alliance argued the policy favours Big Pharma at the expense of smaller innovators. PhRMA, the industry trade group, warned that “tariffs on cutting-edge medicines will increase costs and could jeopardise billions in U.S. investments.” Drugs from the European Union, Japan, South Korea, and Switzerland face a reduced 15% rate under existing trade agreements, while the United Kingdom secured a 10% rate. Analysts expect a wave of merger and acquisition activity as smaller companies without the resources to onshore become takeover targets for larger firms seeking to consolidate their tariff-exempt portfolios (ABC News).
Sensei’s Insight: The M&A angle is where this gets interesting for retail investors. Mid-cap biotech names with single-product portfolios and no U.S. manufacturing suddenly look like bargain acquisition targets for the majors who have already signed MFN deals. Watch the XBI biotech index for unusual options activity over the next 120 days as the clock ticks toward enforcement.
🛢️ OPEC+ Makes a Symbolic Oil Hike Nobody Believes
OPEC+ agreed yesterday to raise oil production quotas by 206,000 barrels per day (bpd) for May, the second consecutive monthly increase from the eight-member “Voluntary” group. The decision amounts to less than 2% of the estimated 12 to 15 million bpd removed from global markets since Iran closed the Strait of Hormuz in early March. As Rystad Energy’s Jorge Leon put it, the increase is “academic” because the key Gulf producers physically cannot export additional oil while the Strait remains blocked. Brent crude sits near $109 a barrel, up roughly 55% from pre-war levels, while physical delivery prices have diverged sharply: dated Brent hit $141.37 on April 2, the highest since 2008. JPMorgan warns prices could spike above $150 if flows remain disrupted into mid-May (Reuters).
The real story is what OPEC+ cannot do. Alternative export routes cover only a fraction of normal Gulf output: Saudi Arabia’s East-West pipeline handles roughly 5 million bpd and the UAE’s Fujairah bypass about 1.8 million bpd, both at or near capacity. The International Energy Agency’s (IEA) record release of 400 million barrels from strategic reserves covers approximately four days of global consumption. IEA Director Fatih Birol called this “the greatest global energy security challenge in history,” adding that “in April, there is nothing,” referring to the transit ships that masked the supply gap in March having now all arrived. The pain is spreading in stages: about 80% of Hormuz oil flows to Asia, where Singapore diesel has climbed above $15 per gallon. Europe faces critical jet fuel shortages, with kerosene prices having doubled. Pakistan has imposed a four-day government workweek, and the Philippines declared a national energy emergency with supplies lasting only until June 30. The crisis extends well beyond crude: the Middle East supplies 45% of the world’s sulphur for fertiliser and 33% of helium used in semiconductors and healthcare. Fertiliser prices are up roughly 33%, and the United Nations Food and Agriculture Organisation projects food prices could average 15% to 20% higher in the first half of 2026 (Reuters Breakingviews).
Sensei’s Insight: Everyone is watching oil. The smarter trade might be watching fertiliser. The Strait carries nearly half the world’s sulphur supply, and Brazil, which accounts for 60% of global soybean exports, depends heavily on Middle Eastern fertiliser inputs. If planting season costs spike, the food inflation wave hits grocery prices months after oil prices come down. Agricultural commodities may be the next leg of this shock.
🇨🇳 Chinese Bonds Near an Inflection Point
Chinese government bonds may be reaching a historic turning point after years of declining yields driven by persistent deflation and sluggish domestic demand. The benchmark 10-year Chinese Government Bond (CGB) yield sits at 1.82%, up from an all-time low of 1.596% in February 2025, and analysts now suggest it could break toward 2% or higher this year. Three forces are converging. First, deflation is easing: China’s Consumer Price Index jumped to 1.3% year-over-year in February, the highest since January 2023, while core CPI surged to 1.8%, its strongest reading since March 2019. Producer Price Index (PPI) deflation narrowed to negative 0.9% from negative 1.4%. Citigroup and Goldman Sachs both expect China’s PPI to turn positive imminently after more than three and a half years of negative readings. Second, the Iran war oil shock is accelerating reflation from the outside in, pushing up import costs for energy and raw materials. Third, massive government bond issuance, with ultra-long bond sales rising from 1.3 trillion to roughly 2 trillion yuan, is creating supply pressure that pushes yields higher (Bloomberg).
The irony is sharp. Bloomberg characterised the situation as “a dangerous cure for record deflation,” because the reflation China has been seeking for years is arriving not through domestic consumer recovery but through an external war-driven commodity shock. Standard Chartered revised its CPI forecast upward to 1.2% from 0.6% and no longer expects a policy rate cut in 2026, warning that “cost-push inflation could further squeeze industrial profits if firms are unable to fully pass higher costs on to consumers.” The property market remains a drag: new home sales contracted 14% by value in 2025, and the housing price index has now declined for 32 consecutive months. Over a quarter of listed Chinese companies are unprofitable, the highest share in 25 years according to Eurasia Group. For global investors, the shift matters because China’s bond market stability has contrasted sharply with the selloff in United States Treasuries and European bonds, giving CGBs an emerging “safe haven” quality. If yields break higher, that narrative unwinds and existing holders face capital losses.
Sensei’s Insight: China getting inflation from war rather than demand is the worst possible version of reflation. It squeezes margins without generating the consumer spending that would actually fix the economy. If PPI turns positive while housing prices keep falling, the People’s Bank of China is stuck between two mandates pulling in opposite directions. Watch the 2% level on the 10-year CGB as the line in the sand.
🔗 Connect with Us
Stay plugged in across platforms:
Sensei on X: sensei_live_
Martyn Lucas on X: MartynInvestor
Vaz on X: eVTOLHUB
📺 YouTube Channel (Live & Replays): Martyn Lucas Investor
This content is for informational and educational purposes only and does not constitute financial advice. Always do your own research. Not financial advice (NFA).
Ty Mr. Sensei great insights